Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418477
Status:
RECRUITING
Last Update Posted:
2024-05-21
First Post:
2024-05-13
Brief Title:
Daratumumab Bortezomib Cyclophosphamide and Dexamethasone Therapy for Patients with MIDD
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-28
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-13
First Submit QC Date:
May 13 2024
Study First Post Date:
2024-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-29
Last Update Post Date:
2024-05-21
Last Update Post Date Type:
ACTUAL